Latest fiscal year 2025 · computed deterministically from XBRL 10-K data · coverage 83%
In fiscal 2025, Merck & Co., Inc. reported revenue of $65.01B, up 1.3% year over year. Operating margin was n/a and net margin 28.1%, on a free-cash-flow margin of 19.0% with capital expenditure at 6.3% of revenue. Every figure is computed directly from MRK's SEC XBRL 10-K filing — deterministic, with no estimates.
| Fiscal year | Revenue | Op margin | Net margin |
|---|---|---|---|
| FY2025 | $65.01B | n/a | 28.1% |
| FY2024 | $64.17B | n/a | 26.7% |
| FY2023 | $60.12B | n/a | 0.6% |
| FY2022 | $59.28B | n/a | 24.5% |
| FY2021 | $48.70B | n/a | 26.8% |
How does MRK compare against its actual peer set?
A CompsDesk subscription covers unlimited benchmark packs on any covered company: up to 19 metrics (6 core guaranteed) × up to 5 fiscal years × up to 12 chosen peers, percentile placement, the subject's figures cited to their SEC tag, form and period with every company identified by its CIK, PDF-ready HTML + CSV, generated on demand.
Source: SEC EDGAR XBRL (10-K filings), latest filed values. "n/a" = not disclosed under mapped tags — never estimated. Informational benchmarking, not investment advice. © CompsDesk / Sam Arora.